rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Lakhmir S. Chawla

Director

Company insider

Files Form 4 as: Director, Revelation Biosciences; Chief Medical Officer, La Jolla Pharmaceutical Co.

Every Form 4 they filed

In numbers

Trades disclosed
118
Buys
5
Sells
0
Bought
$86K
Sold
$0
Companies
2
Companies where not an officer
1
First trade
31 Aug 2015
Last trade
17 Aug 2026
Last filed
18 Aug 2026

Companies traded

Where they are an officer
La Jolla Pharmaceutical CoOfficer · last 15 Sep 20205 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
REVB Revelation BiosciencesDirector · Biotechnology · last 17 Aug 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Aug 2026filed 18 Aug 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A—32,011 at $0.00filing
17 Aug 2026filed 18 Aug 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A—32,011 at $0.00filing
3 Feb 2026filed 5 Feb 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code F$4,1832,261 at $1.85filing
3 Feb 2026filed 5 Feb 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code F$4,1832,261 at $1.85filing
8 Jan 2026filed 12 Jan 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A$38K41,981 at $0.90filing
8 Jan 2026filed 12 Jan 2026REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A$38K41,981 at $0.90filing
29 Oct 2025filed 31 Oct 2025REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A$20K15,625 at $1.28filing
11 Feb 2025filed 13 Feb 2025REVB Revelation BiosciencesBiotechnologySEC FORM 4 Code A$700181 at $3.87filing
15 Sep 2020filed 17 Sep 2020La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—286 at $0.00filing
15 Sep 2020filed 17 Sep 2020La Jolla Pharmaceutical CoSEC FORM 4 Code A$1,101286 at $3.85filing
31 Aug 2020filed 2 Sep 2020La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—550 at $0.00filing
31 Aug 2020filed 2 Sep 2020La Jolla Pharmaceutical CoSEC FORM 4 Code A$1,964550 at $3.57filing
14 Aug 2020filed 18 Aug 2020La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—589 at $0.00filing
14 Aug 2020filed 18 Aug 2020La Jolla Pharmaceutical CoSEC FORM 4 Code A$1,967589 at $3.34filing
31 Jul 2020filed 4 Aug 2020La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—581 at $0.00filing
31 Jul 2020filed 4 Aug 2020La Jolla Pharmaceutical CoSEC FORM 4 Code A$1,964581 at $3.38filing
15 Jul 2020filed 17 Jul 2020La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—521 at $0.00filing
15 Jul 2020filed 17 Jul 2020La Jolla Pharmaceutical CoSEC FORM 4 Code A$1,964521 at $3.77filing
1 Jul 2020filed 17 Sep 2020La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—60,000 at $0.00filing
30 Jun 2020filed 1 Jul 2020La Jolla Pharmaceutical Cooption or derivativeSEC FORM 4 Code A—543 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed5

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.